RAPT Therapeutics

Home » RAPT Therapeutics

IPO

RAPT Therapeutics

Biopharmaceutical

We are a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.

Symbol

RAPT

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Anticipated Date
August 1, 2019

Underwriters
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED,WELLS FARGO SECURITIES, LLC

This offering is no longer available

To view the prospectus for RAPT Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253